
Lenalidomide monotherapy and in combination with cytarabine, daunorubicin and etoposide for high-risk myelodysplasia and acute myeloid leukaemia with chromosome 5 abnormalities
Keywords: لوسمی میلوئید حاد; Myelodysplasia; Acute myeloid leukaemia; Chromosome 5; Lenalidomide; Chemotherapy